Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Growth and Development”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 433 records · Page 24Linked to original sources

Review of some aspects of growth and development of feedlot cattle.

Growth in animals is defined as accretion of protein, fat and bone. Although growth typically is measured as the change in live weight, nutrient retention is estimated more precisely by measuring empty body weight and composition, whereas production economics are measured ideally through carcass weights and quality. As a percentage of live weight gain, carcass weight gain usually is a much higher percentage during the feedlot phase than during the growing phase of production because dressing percentage (ratio of carcass:live weight) increases with maturation and is greater with concentrate than with roughage diets. At a given fraction of mature body size (maximum body protein mass), body fat percentage seems to be a constant. Mature size may be altered genetically and nutritionally. Protein accretion declines to zero when cattle reach their mature body size (approximately 36% fat in empty body weight in modern cattle) even though mature animals can continue to accrete fat. Although fat accretion can be reduced by limiting the supply of net energy, rate of fat accretion by finishing steers given ad libitum access to high-concentrate diets seems to reach a plateau at approximately 550 g daily. Protein mass, in contrast, increases in proportion to empty body weight. The protein:fat ratio of the carcass can be increased through increasing mature size, by administering hormones or hormonal modifiers, by limiting energy intake during the growing period or finishing period, or by slaughtering cattle at an earlier stage of maturity. Energetically, efficiency of accretion of fat is approximately 1.7 times that of protein. But because more water is stored with deposited protein than with deposited fat, lean tissue gain is four times as efficient as accretion of fat tissue. Conversion of protein to fat is very inefficient, suggesting that excess protein is utilized inefficiently.

Animals↗

[The effects of the GH, IGF-I and IGF-IBP3 gene on growth and development traits of Nanyang cattle in different growth period].

This study was conducted to identify polymorphisms of the Nangyang cattle's growth hormone (GH) and insulin-like growth factor-I (IGF-I) and insulin-like growth factor-I binding protein 3(IGF-IBP3) gene by the single nucleotide Polymorphisms and Polymerase chain reaction-based restriction fragment length polymorphism and to study association of polymorphisms identified in these genes with growth traits of the birth, 6 months, 12 months, 18 months, 24 months and 36 months. Results from the analysis showed a significant association of the BB genotype in the promoter of GH gene (GH-P5) with higher body length and body height during from 6 month to 18 month. From 24 month to 36 month, the IGF-IBP3 locus has a dominance modulation and control effect on backbody in Nanyang Cattle, and the BB genotype with higher Rump width than AA.

Animals↗

A key transcription factor for eukaryotic initiation factor-2 alpha is strongly homologous to developmental transcription factors and may link metabolic genes to cellular growth and development.

In response to growth, metabolic, and other signals, eukaryotic cells regulate protein biosynthesis through post-translational mechanisms which target the alpha subunit of eukaryotic initiation factor-2 (eIF-2 alpha). Previous efforts to study transcriptional mechanisms underlying this regulation identified a novel transcription factor (alpha-Pal) for the eIF-2 alpha gene. To gain insights into the overall biological function of alpha-Pal, we cloned its cDNA. Sequence analysis of the encoded protein reveals that alpha-Pal is a putative bZIP transcription factor. Surprisingly, both the protein sequence and the DNA-recognition site (TGCGCATGCGCA) of this human protein are strongly homologous to those of two evolutionarily distant developmental transcription factors, P3A2 and ewg. Since P3A2 directs territory-specific transcription of muscle genes in sea urchin embryos, and ewg apparently directs transcription of flight muscle and neuronal genes in Drosophila embryos, it is likely that alpha-Pal directs similar gene transcription during human embryogenesis. In other studies, we also identified genes containing alpha-Pal-binding sequences as those involved in cellular proliferation, or the growth-responsive metabolic pathways, energy transduction, translation, and DNA replication/repair. Such data suggest that alpha-Pal also functions to modulate the transcription of metabolic genes required for cellular growth.

Amino Acid Sequence↗

Growth and development: physical, mental, and social aspects.

This article details normal adolescent growth and development, including Tanner staging. Problems of abnormal adolescent growth and development are also discussed, along with treatment of short stature. Tables and graphs outlining these topics are included.

Adolescent↗

Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: elevated platelet counts, prolonged survival, and tumor growth inhibition.

Kasabach-Merritt Syndrome (KMS) is seen in children with large vascular tumors. KMS is characterized by very low platelet counts and a consumption of coagulation factors causing life-threatening complications. It has been proposed that thrombopenia in these patients is caused by intratumoral trapping of platelets. The truncated form of the cMpl-receptor ligand thrombopoietin, pegylated human megakaryocyte growth and development factor (Peg-rHuMGDF), is an agent that stimulates platelet production. We hypothesized that stimulation of the platelet production would prevent the life-threatening complications of patients with KMS owing to low platelet counts. In a mouse model of KMS, with tumors derived from a hemangioendothelioma cell line, we studied the effect of Peg-rHuMGDF. Treatment with Peg-rHuMGDF (10 microg/kg/day intraperitoneally) increased platelet counts by 7-8-fold compared with control tumor-bearing mice after 11 d of treatment (p < 0.001, n = 8). Survival was significantly increased, with 50% of treated animals alive at 1 mo versus 0% in untreated controls. Interestingly, we also observed an inhibition of tumor growth by 75% (p < 0.001, n = 8). Hematoxylin and eosin staining showed fresh fibrin clots in the treated tumors, suggesting that higher platelet counts caused intravascular thrombosis of tumor vessels. We conclude that increased platelet production in this model of KMS resulted in an antivascular tumor effect via platelet trapping. Further, we propose that thrombopoietin may be of critical value in preventing life-threatening complications from KMS.

Animals↗

The use of phosphorus 32 in studies on Plasmodium gallinaceum. I. The development of a method for the quantitative determination of parasite growth and development in vitro.

A quantitative method for following parasite growth in vitro is described. The method is based on the determination of the degree of incorporation of phosphorus into the nucleic acids, in particular desoxypentose nucleic acids, of the parasitized cell. Phosphorus incorporation is measured by utilizing the radioactive isotope, P(32). The degree of phosphorus incorporation into DNA was found to be closely correlated with estimates of parasite growth based on stained film examinations of intact cell preparations. The isotope was likewise found to be incorporated into the DNA of preparations in which the host cell had been disrupted by lysis and the extent of this incorporation also paralleled the impressions gained from smear examinations. It is suggested that this method provides a sensitive and objective method of studying parasite growth.

Animals↗

Growth and development in orthodontics.

The recent literature on growth and development of the face and dentition includes important articles about assessment of growth, maturation, growth in the vertical dimension, treatment effects, experimental growth, and craniofacial anomalies. An underlying theme can be detected in these reports--the individuality of the child and his or her response to treatment. Central trends can be determined from growth data, but these generalizations should be applied with caution. When formulating treatment goals and planning mechanics, great variability can exist among growing children.

Adolescent↗

Early childhood growth and development in rural Guatemala.

BACKGROUND: Small size at birth and in early childhood has been associated with impaired neurodevelopment in studies from developing countries, but few have examined associations with growth. AIMS: The objective of this study was to assess the relationship between growth and neurodevelopment during early childhood (birth-36 months). DESIGN: Multivariate regression models were used to analyze the data collected in the course of a study of pregnancy outcomes and early childhood growth and development carried out in rural Guatemala in 1991-1999. Motor and mental development scores were based on the Psychomotor and Mental Development Indices, respectively, derived from the administration of an adapted version of the Bayley Scales of Infant Development (Second Edition, 1993) at 6, 24 and 36 months. Z-scores for height-for-age (HAZ), weight-for-age (WAZ), and head circumference-for-age (HCZ) were used as indicators of attained size; changes in these Z-scores over time represent growth. RESULTS: Birth size was significantly associated with child development at 6 and 24 months. Gains in length and weight during the first 24 months were positively associated with child development, whereas growth from 24 to 36 months age was not associated with child development at 36 months. Motor development was more strongly and consistently related to child growth than was mental development. Head circumference gain after 6 months was not a significant predictor of child development at 24 and 36 months. CONCLUSIONS: Small size at birth and poor physical growth during the first 24 months are related to neurodevelopmental delays. More evidence from developing countries will help explain the underlying mechanisms and identify appropriate interventions to prevent neurodevelopmental delay in early childhood.

Body Height↗

Fetal growth and development.

The advent and advancement of ultrasound technology have proved to be invaluable tools in the assessment of the fetus while still in the intrauterine environment. Ultrasound has given and continues to give us fresh insights into many aspects of the developing human. The area of fetal growth and development is a difficult one. Our lack of knowledge of the basic controlling influences has inhibited investigations in this area, but ultrasound has at least allowed us to begin to scratch the surface of this complex subject. We can now obtain very useful clinical information that usually has excellent correlation with gestational age, fetal size, fetal structure, and fetal function. We are just now beginning to document the natural history of many fetal abnormalities. Undoubtedly, advances in our knowledge of genetics and molecular biology and continuing technologic advances in imaging techniques will provide fresh insights and allow us to continue to probe and unlock the mysteries of fetal growth and development.

Biometry↗

Final height in patients with constitutional delay of growth and development from tall statured families.

Constitutional delay of growth and development occurs not only in children of short statured families but also in children of tall statured families. We represent the final height from 12 boys and 21 girls cared for CDGD. The mean target height for boys was 186.6 cm and for girls 173.6 cm and final heights were 191.2 and 176.9 cm, respectively. The final height of 14 patients exceeded the mean target height by more than 4 cm, nine patients exceeded the familial target height range. Only one boy did not reach the familial target height range. We conclude that CDGD occurs in equal quantities in boys and in girls irrespective of the familial height score and will lead to normal final heights within the familial target height range. In general, no therapy is necessary to alter the progression of CDGD.

Adolescent↗

[Molecular genetic mechanism of sodium arsenite on growth and development].

OBJECTIVE: To study the effects of sodium arsenite on gene expression related to growth and development and explored the molecular mechanism of arsenic effects using gene chips. METHODS: Normal human hepatic cells were dripped on chips and then hybrided with the first strand of cDNA from hepatic cell exposed to different concentration of sodium arsenite. Gene sequence of clone differently expressed was determined and then defined which gene it was and finally those genes which associated with growth and development were identified. RESULTS: The p55 gene expression level of two experimental groups was severaly 2.21 and 2.93 times as the control group. The PL gene level of two experimental groups were 0.13 and 0.27 times as the control group, and the HOXA10 gene level was 0.22 and 0.35 times of the control group. These results indicated that sodium arsenite increase p55 gene expression, and inhibited PL and HOXA10 gene expression. CONCLUSIONS: The sodium arsenite could affect the gene expression related to growth and development and it is shown that the molecular genetic mechanism of sodium arsenite is related to growth and development.

Arsenites↗

Effect of nerve repair after unilateral partial facial paralysis on craniofacial growth and development.

The effect of partial transection, coaptation, and freezing of the left facial nerve on craniofacial growth and development was investigated. Twelve-day-old New Zealand White rabbits were randomly assigned to four groups: control group (n = 15), nerve ablation group (n = 15) with a surgically induced partial facial paralysis, nerve coaptation group (n = 15) with a surgically induced partial facial paralysis treated by immediate microsurgical nerve coaptation, and nerve freezing group (n = 13) with a freezing-induced partial facial paralysis. All animals were operated on at the age of 12 days; follow-up evaluations were performed at the ages of 2 months (end-point prepubertal growth) and 6 months (full grown). Computerized dorsoventral roentgencephalometric analysis and computer tomographic three-dimensional volumetric measurements were performed at both ages. Roentgencephalometric analysis revealed that the growth disturbances of the nerve ablation group and the nerve coaptation group were analogous. In contrast, in the nerve freezing group, hardly any growth disturbances as compared with the control group were seen. The CT volume measurements revealed a significant left-right difference in maxillary volume at the ages of 2 and 6 months in the nerve coaptation group as compared with the control group. Muscle histomorphometric analysis revealed a shift in muscle fiber composition in the nerve coaptation group and the nerve freezing group, with an increase of type I fibers at the cost of type IIA fibers. This shift was significantly less pronounced in the latter than in the former. Nerve histomorphometric analysis revealed a significant increase in the number of nerve fibers in the nerve coaptation group as compared with the control group. In the nerve freezing group, the increase in the number of nerve fibers was not significantly different as compared with the control group and the nerve coaptation group. Both the equivalent diameter and the myelin area were equally reduced in the nerve coaptation and nerve freezing groups. Thus, the nerve coaptation group and the nerve freezing group did not differ significantly in the extent of nerve recovery, although they differed in the extent of muscle recovery. The extent of muscle recovery, in turn, was related to the extent of abnormal craniofacial growth and development. Indeed, the growth and development were hardly abnormal in the nerve freezing group and as abnormal as after untreated paralysis in the nerve coaptation group. Therefore, factors related to nerve regeneration, other than those assessed by nerve histomorphology, were considered to be responsible for these differences between both groups. The duration of the denervation time was regarded to be considerably shorter in the nerve freezing group than in the nerve coaptation group, resulting in the observed improved muscle recovery. The difference in the degree of axonal malalignment between both groups was considered to be negligible, because of the tolerance toward axonal malalignment at neonatal age.

Animals↗

[The early feeding of premature and low birth weight infants with breast milk. II. Growth and development within the first year of life (author's transl)].

Growth and development of 172 infants with low birth weight (82 AFD, 90 SFD) were controlled within the first year of life. Head growth of AFD infants kept within normal limits during the whole time. The head circumference of the SFD infants was smaller within the first two months, from the third month onwards there was no signficant difference between AFD and SFD infants. The difference in body weight between AFD and SFD was significant up to the fifth month. Psychomotor development was within normal limits in 165 of the 172 infants, seven children developed signs of cerebral palsy. The incidence of spastic diplegia in infants with a birth weight below 1500 gm was 2.4%. The favourable outcome seems to be at least partially due to the early high caloric feeding.

Birth Weight↗

Trace minerals in human growth and development.

Trace mineral deficiencies may affect several biological functions in humans, including physical growth, psychomotor development and immunity. We have reviewed the mechanisms whereby several trace mineral deficiencies may affect these biological functions at different ages (fetal life, infancy, childhood and adolescence), as well as the evidence supporting this association. We describe the effects of zinc deficiency on the hormonal regulation of growth and sexual development in both humans and animal models. We provide data regarding the effects of iron deficiency on growth and psychomotor development. We mention the effects of copper, manganese, selenium and iodine deficiencies on growth and development. We conclude that iron deficiency may affect psychomotor development, but does not appear to affect growth. Zinc deficiency may cause growth retardation and psychomotor delay.

Adolescent↗

Trace minerals in human growth and development.

Trace mineral deficiencies may affect several biological functions in humans, including physical growth, psychomotor development and immunity. We have reviewed the mechanisms whereby several trace mineral deficiencies may affect these biological functions at different ages (fetal life, infancy, childhood and adolescence), as well as the evidence supporting this association. We describe the effects of zinc deficiency on the hormonal regulation of growth and sexual development in both humans and animal models. We provide data regarding the effects of iron deficiency on growth and psychomotor development. We mention the effects of copper, manganese, selenium and iodine deficiencies on growth and development. We conclude that iron deficiency may affect psychomotor development, but does not appear to affect growth. Zinc deficiency may cause growth retardation and psychomotor delay.

Child↗

Facial volume changes during normal human growth and development.

BACKGROUND: To describe normal soft tissue growth and development of the human face through volume changes and to assess the presence of sexual dimorphism. METHODS: Facial landmark identifications (2,023) were performed on 1,347 healthy Caucasian children and adolescents, ages 6-18 yr, and young adults, ages 19-32 yr. Three-dimensional coordinates of 22 facial landmarks were collected by automated infrared photogrammetry. Facial volumes and selected linear distances and ratios were calculated and averaged for age and sex. RESULTS: Whereas in females in the 14-15 age group, the face had almost completed its growth relative to the adult group, in males a large increase was still to occur, in general agreement with previous reports on craniofacial growth, which suggested a strong tendency in males for growth to continue for several years beyond that seen in females. The male vs. female comparison reflected the different growth patterns. On average, within each age group volumes were significantly larger in males than in females, with some exceptions in the 11-12 age group, where female growth velocity showed a spurt. Sexual dimorphism in facial volume did not appear in different parts of the face to the same extent: a large part of male facial volume preponderance occurred in the lower third of the face. CONCLUSIONS: From 6 yr of age to adulthood, facial soft tissues increased their volumes by >40%, with different growth patterns in boys and girls.

Adolescent↗